APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pirfenidone Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pirfenidone Drugs Industry Growth and Trends Forecast to 2032

23 December 202597 pages

Choose your research edition.

Industry ResearchPirfenidone Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Pirfenidone Drugs Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Pirfenidone Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pirfenidone Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pirfenidone Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pirfenidone Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pirfenidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pirfenidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pirfenidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pirfenidone Drugs include Teva, Sandoz, Roche, Kawin, Gyre Pharmaceuticals, ScieGen Pharmaceuticals, Apotex, Amneal Pharmaceuticals and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pirfenidone Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pirfenidone Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pirfenidone Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pirfenidone Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pirfenidone Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pirfenidone Drugs Market by Company

Teva

Sandoz

Roche

Kawin

Gyre Pharmaceuticals

ScieGen Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Accord Healthcare

Pirfenidone Drugs Segment by Type

Capsules

Tablets

Pirfenidone Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Pirfenidone Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pirfenidone Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pirfenidone Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pirfenidone Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pirfenidone Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pirfenidone Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsules Table 2. Major Company of Tablets Table 3. Global Pirfenidone Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pirfenidone Drugs Sales by Type (2021-2026) & (k units) Table 5. Global Pirfenidone Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pirfenidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pirfenidone Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Pirfenidone Drugs Price by Type (2021-2026) & (US$/unit) Table 9. Global Pirfenidone Drugs Sales by Type (2027-2032) & (k units) Table 10. Global Pirfenidone Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pirfenidone Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pirfenidone Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Pirfenidone Drugs Price by Type (2027-2032) & (US$/unit) Table 14. North America Pirfenidone Drugs Sales by Type (2021-2026) & (k units) Table 15. North America Pirfenidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pirfenidone Drugs Sales by Type (2021-2026) & (k units) Table 17. Europe Pirfenidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pirfenidone Drugs Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Pirfenidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pirfenidone Drugs Sales by Type (2021-2026) & (k units) Table 21. Latin America Pirfenidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pirfenidone Drugs Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Pirfenidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Pirfenidone Drugs Industry Trends Table 25. Pirfenidone Drugs Industry Drivers Table 26. Pirfenidone Drugs Industry Opportunities and Challenges Table 27. Pirfenidone Drugs Industry Restraints Table 28. Global Pirfenidone Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pirfenidone Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Pirfenidone Drugs Sales by Company (2021-2026) & (k units) Table 31. Global Pirfenidone Drugs Sales Share by Company (2021-2026) Table 32. Global Pirfenidone Drugs Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Pirfenidone Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pirfenidone Drugs Major Company Production Sites and Headquarters Table 35. Global Pirfenidone Drugs Company, Product Type & Application Table 36. Global Pirfenidone Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pirfenidone Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pirfenidone Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pirfenidone Drugs Sales by Region (2021-2026) & (k units) Table 41. Global Pirfenidone Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pirfenidone Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pirfenidone Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Pirfenidone Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Pirfenidone Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Pirfenidone Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pirfenidone Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pirfenidone Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Pirfenidone Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Pirfenidone Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pirfenidone Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Pirfenidone Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pirfenidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pirfenidone Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Pirfenidone Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Pirfenidone Drugs Sales by Application (2027-2032) & (k units) Table 57. Global Pirfenidone Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pirfenidone Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pirfenidone Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Pirfenidone Drugs Price by Application (2027-2032) & (US$/unit) Table 61. North America Pirfenidone Drugs Sales by Application (2021-2026) & (k units) Table 62. North America Pirfenidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pirfenidone Drugs Sales by Application (2021-2026) & (k units) Table 64. Europe Pirfenidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pirfenidone Drugs Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Pirfenidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pirfenidone Drugs Sales by Application (2021-2026) & (k units) Table 68. Latin America Pirfenidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pirfenidone Drugs Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Pirfenidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Pirfenidone Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Pirfenidone Drugs Product Portfolio Table 75. Teva Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Pirfenidone Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sandoz Pirfenidone Drugs Product Portfolio Table 80. Sandoz Recent Development Table 81. Roche Company Information Table 82. Roche Business Overview Table 83. Roche Pirfenidone Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Roche Pirfenidone Drugs Product Portfolio Table 85. Roche Recent Development Table 86. Kawin Company Information Table 87. Kawin Business Overview Table 88. Kawin Pirfenidone Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Kawin Pirfenidone Drugs Product Portfolio Table 90. Kawin Recent Development Table 91. Gyre Pharmaceuticals Company Information Table 92. Gyre Pharmaceuticals Business Overview Table 93. Gyre Pharmaceuticals Pirfenidone Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Gyre Pharmaceuticals Pirfenidone Drugs Product Portfolio Table 95. Gyre Pharmaceuticals Recent Development Table 96. ScieGen Pharmaceuticals Company Information Table 97. ScieGen Pharmaceuticals Business Overview Table 98. ScieGen Pharmaceuticals Pirfenidone Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. ScieGen Pharmaceuticals Pirfenidone Drugs Product Portfolio Table 100. ScieGen Pharmaceuticals Recent Development Table 101. Apotex Company Information Table 102. Apotex Business Overview Table 103. Apotex Pirfenidone Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Apotex Pirfenidone Drugs Product Portfolio Table 105. Apotex Recent Development Table 106. Amneal Pharmaceuticals Company Information Table 107. Amneal Pharmaceuticals Business Overview Table 108. Amneal Pharmaceuticals Pirfenidone Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Amneal Pharmaceuticals Pirfenidone Drugs Product Portfolio Table 110. Amneal Pharmaceuticals Recent Development Table 111. Accord Healthcare Company Information Table 112. Accord Healthcare Business Overview Table 113. Accord Healthcare Pirfenidone Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Accord Healthcare Pirfenidone Drugs Product Portfolio Table 115. Accord Healthcare Recent Development Table 116. North America Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America Pirfenidone Drugs Sales by Country (2021-2026) & (k units) Table 118. North America Pirfenidone Drugs Sales Market Share by Country (2021-2026) Table 119. North America Pirfenidone Drugs Sales Forecast by Country (2027-2032) & (k units) Table 120. North America Pirfenidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. North America Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Pirfenidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Pirfenidone Drugs Market Share by Country (2021-2026) Table 124. North America Pirfenidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Pirfenidone Drugs Market Share Forecast by Country (2027-2032) Table 126. Europe Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe Pirfenidone Drugs Sales by Country (2021-2026) & (k units) Table 128. Europe Pirfenidone Drugs Sales Market Share by Country (2021-2026) Table 129. Europe Pirfenidone Drugs Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe Pirfenidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Pirfenidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Pirfenidone Drugs Market Share by Country (2021-2026) Table 134. Europe Pirfenidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Pirfenidone Drugs Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Pirfenidone Drugs Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific Pirfenidone Drugs Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Pirfenidone Drugs Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific Pirfenidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Pirfenidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Pirfenidone Drugs Market Share by Country (2021-2026) Table 144. Asia-Pacific Pirfenidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Pirfenidone Drugs Market Share Forecast by Country (2027-2032) Table 146. Latin America Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America Pirfenidone Drugs Sales by Country (2021-2026) & (k units) Table 148. Latin America Pirfenidone Drugs Sales Market Share by Country (2021-2026) Table 149. Latin America Pirfenidone Drugs Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America Pirfenidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Pirfenidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Pirfenidone Drugs Market Share by Country (2021-2026) Table 154. Latin America Pirfenidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Pirfenidone Drugs Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Pirfenidone Drugs Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa Pirfenidone Drugs Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Pirfenidone Drugs Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa Pirfenidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Pirfenidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Pirfenidone Drugs Market Share by Country (2021-2026) Table 164. Middle East and Africa Pirfenidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Pirfenidone Drugs Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Pirfenidone Drugs Distributors List Table 169. Pirfenidone Drugs Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Pirfenidone Drugs Image Figure 2. Global Pirfenidone Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pirfenidone Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Pirfenidone Drugs Sales (2021-2032) & (k units) Figure 5. Capsules Image Figure 6. Global Capsules Sales YoY Growth (2021-2032) & (k units) Figure 7. Tablets Image Figure 8. Global Tablets Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Pirfenidone Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pirfenidone Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Pirfenidone Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Pirfenidone Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Pirfenidone Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pirfenidone Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pirfenidone Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pirfenidone Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pirfenidone Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pirfenidone Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pirfenidone Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pirfenidone Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pirfenidone Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (k units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Pirfenidone Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pirfenidone Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Pirfenidone Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Pirfenidone Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Pirfenidone Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Pirfenidone Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Pirfenidone Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Pirfenidone Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Pirfenidone Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Pirfenidone Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Pirfenidone Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Pirfenidone Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Pirfenidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Pirfenidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Pirfenidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Pirfenidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pirfenidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Pirfenidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pirfenidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pirfenidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pirfenidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Pirfenidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pirfenidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Pirfenidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pirfenidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Pirfenidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pirfenidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Pirfenidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pirfenidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Pirfenidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pirfenidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Pirfenidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Pirfenidone Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Pirfenidone Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Tablets
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Teva
  • Sandoz
  • Roche
  • Kawin
  • Gyre Pharmaceuticals
  • ScieGen Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pirfenidone Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pirfenidone Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pirfenidone Drugs Market by Type
  6. 1.3.1 Capsules
  7. 1.3.2 Tablets
  8. 1.4 Global Pirfenidone Drugs Market Size by Type
  9. 1.4.1 Global Pirfenidone Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pirfenidone Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pirfenidone Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pirfenidone Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pirfenidone Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pirfenidone Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pirfenidone Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pirfenidone Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pirfenidone Drugs Industry Trends
  2. 2.2 Pirfenidone Drugs Industry Drivers
  3. 2.3 Pirfenidone Drugs Industry Opportunities and Challenges
  4. 2.4 Pirfenidone Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pirfenidone Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Pirfenidone Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Pirfenidone Drugs Price (2021-2026)
  4. 3.4 Global Pirfenidone Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pirfenidone Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Pirfenidone Drugs Company, Product Type & Application
  7. 3.7 Global Pirfenidone Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pirfenidone Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pirfenidone Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pirfenidone Drugs Tier 1, Tier 2, and Tier 3
4 Pirfenidone Drugs Regional Status and Outlook
  1. 4.1 Global Pirfenidone Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pirfenidone Drugs Historic Market Size by Region
  3. 4.2.1 Global Pirfenidone Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pirfenidone Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pirfenidone Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pirfenidone Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Pirfenidone Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pirfenidone Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pirfenidone Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pirfenidone Drugs by Application
  1. 5.1 Pirfenidone Drugs Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Pirfenidone Drugs Market Size by Application
  6. 5.2.1 Global Pirfenidone Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pirfenidone Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pirfenidone Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pirfenidone Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pirfenidone Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pirfenidone Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pirfenidone Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pirfenidone Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pirfenidone Drugs Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Pirfenidone Drugs Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roche Pirfenidone Drugs Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Kawin
  20. 6.4.1 Kawin Company Information
  21. 6.4.2 Kawin Business Overview
  22. 6.4.3 Kawin Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kawin Pirfenidone Drugs Product Portfolio
  24. 6.4.5 Kawin Recent Developments
  25. 6.5 Gyre Pharmaceuticals
  26. 6.5.1 Gyre Pharmaceuticals Company Information
  27. 6.5.2 Gyre Pharmaceuticals Business Overview
  28. 6.5.3 Gyre Pharmaceuticals Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gyre Pharmaceuticals Pirfenidone Drugs Product Portfolio
  30. 6.5.5 Gyre Pharmaceuticals Recent Developments
  31. 6.6 ScieGen Pharmaceuticals
  32. 6.6.1 ScieGen Pharmaceuticals Company Information
  33. 6.6.2 ScieGen Pharmaceuticals Business Overview
  34. 6.6.3 ScieGen Pharmaceuticals Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ScieGen Pharmaceuticals Pirfenidone Drugs Product Portfolio
  36. 6.6.5 ScieGen Pharmaceuticals Recent Developments
  37. 6.7 Apotex
  38. 6.7.1 Apotex Company Information
  39. 6.7.2 Apotex Business Overview
  40. 6.7.3 Apotex Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Apotex Pirfenidone Drugs Product Portfolio
  42. 6.7.5 Apotex Recent Developments
  43. 6.8 Amneal Pharmaceuticals
  44. 6.8.1 Amneal Pharmaceuticals Company Information
  45. 6.8.2 Amneal Pharmaceuticals Business Overview
  46. 6.8.3 Amneal Pharmaceuticals Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Amneal Pharmaceuticals Pirfenidone Drugs Product Portfolio
  48. 6.8.5 Amneal Pharmaceuticals Recent Developments
  49. 6.9 Accord Healthcare
  50. 6.9.1 Accord Healthcare Company Information
  51. 6.9.2 Accord Healthcare Business Overview
  52. 6.9.3 Accord Healthcare Pirfenidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Accord Healthcare Pirfenidone Drugs Product Portfolio
  54. 6.9.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Pirfenidone Drugs Sales by Country
  2. 7.1.1 North America Pirfenidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pirfenidone Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Pirfenidone Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pirfenidone Drugs Market Size by Country
  6. 7.2.1 North America Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pirfenidone Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Pirfenidone Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pirfenidone Drugs Sales by Country
  2. 8.1.1 Europe Pirfenidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pirfenidone Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Pirfenidone Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pirfenidone Drugs Market Size by Country
  6. 8.2.1 Europe Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pirfenidone Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pirfenidone Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pirfenidone Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Pirfenidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pirfenidone Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pirfenidone Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pirfenidone Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pirfenidone Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pirfenidone Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pirfenidone Drugs Sales by Country
  2. 10.1.1 South America Pirfenidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pirfenidone Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Pirfenidone Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pirfenidone Drugs Market Size by Country
  6. 10.2.1 South America Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pirfenidone Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Pirfenidone Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pirfenidone Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Pirfenidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pirfenidone Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pirfenidone Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pirfenidone Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Pirfenidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pirfenidone Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pirfenidone Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pirfenidone Drugs Value Chain Analysis
  2. 12.1.1 Pirfenidone Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pirfenidone Drugs Production Mode & Process
  7. 12.2 Pirfenidone Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pirfenidone Drugs Distributors
  10. 12.2.3 Pirfenidone Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst